Do I need a CRO? An honest answer for emerging biotechs

If you are a small biotech heading into your first or second trial, someone has already told you that you need a full-service CRO. Someone else has told you CROs will burn half your raise. Both are sometimes right, and since we are a site network rather than a CRO, we can afford to answer this honestly: we get paid either way.

When you genuinely need one

Multi-country studies. Complex regulatory strategy across regions. Large Phase 3 programs where project management itself is a full-time department. If your trial spans 40 sites in six countries, a CRO is not overhead, it is infrastructure, and trying to save that money usually costs more later.

When you might not

A single-country Phase 1 or 2 with a handful of sites is a different animal. Plenty of emerging sponsors run these with a lean internal clinical lead plus functional providers: a data management shop, a biostatistics group, an independent monitor, and sites that carry more of the operational weight than traditional sites can. The math can be dramatically better, but only if the pieces you hire are genuinely strong, because there is no CRO project manager catching what falls between them.

The question underneath the question

What most emerging biotechs are actually asking is: who will keep this trial from stalling? The honest answer is that enrollment, not paperwork, is where most small-sponsor trials die, and enrollment lives at the site level regardless of which model you pick. A mediocre CRO with strong sites beats an excellent CRO with weak ones, every time. So whichever direction you choose, interrogate the sites first: where do their patients actually come from, who employs the coordinators, and what happens when screening falls behind.

Where we fit, stated plainly

We work under CROs on some studies and directly with sponsors on others, so this is not a pitch against anyone. For a first-time sponsor, our embedded model does carry more of the load than a traditional site: feasibility from real patient counts, coordinators on our payroll, central regulatory and quality, and a medical monitor inside the network. Some sponsors find that lets them go lighter on the middle layer. Others still want a CRO wrapped around everything, and that works too.

If you are weighing the decision, send us the protocol synopsis. We will tell you what the site side can realistically carry, within 48 business hours, and you can size the rest from there. trials@stryderesearch.com.